MEA | Middle East CEO of the Year Awards 2024 4 Hematology Chief Medical Executive of the Year 2024: Dr May Almoshary The healthcare industry in Saudi Arabia is growing at a rapid pace, estimated to be valued at $23 billion by 2027. As the country’s healthcare infrastructure strengthens, driven by the government’s commitment to advancing healthcare resources, the sector leverages cutting-edge technologies and dedicated research to further facilitate change. Dr May Almoshary is a renowned hematologist, assistant professor, and Chief Executive Officer of a leading healthcare institution in Saudi Arabia, who has been recently awarded for her contributions in the Middle East CEO of the Year Awards 2024. Below, we take a closer look at how Dr Almoshary is currently championing the Saudi Arabian healthcare revolution. ased in Riyadh, Dr Almoshary is on a mission to transform healthcare delivery throughout the region, using innovation and strategic partnerships to achieve this. Striving to align the nation with international healthcare standards, Dr Almoshary aims to provide the highest quality standards of care. Boasting more than two decades of experience in healthcare management, Dr Almoshary is renowned for her commitment to operational excellence and patientcentred care. Dr Almoshary’s journey to becoming a CEO is characterised by the leadership roles she has held across various healthcare settings. Beginning her career as a consultant in hematology, Dr Almoshary gradually ascended through various prestigious positions, including the role of Chairperson of Transfusion Medicine at King Fahad Medical City, and Chief Medical Officer at Private Diagnostics. Over the years, Dr Almoshary has found that her core competencies lie in medical research, public health, quality patient care, and laboratory skills, each ability honed by her vast experience across the sector. Each role has equipped Dr Almoshary with valuable insights into operational management, strategic planning, and the importance of compliance within healthcare. Now, as CEO of Private Diagnostics, Dr Almoshary applies this knowledge to her current role to effectively lead her team to success. She is committed to working collaboratively with multidisciplinary teams and building and maintaining strong relationships with industry connections, understanding the important role collaboration plays in advancing healthcare. A skilled leader, Dr Almoshary opts for an engaging leadership style that allows her to foster open communication and collaboration within her team. She ensures that her vision is communicated clearly across the organisation, empowering each team member to contribute towards the firm’s shared goals. By nurturing a positive culture focused on continuous improvement, Dr Almoshary effectively inspires her team to strive for excellence. Dr Almoshary’s relentlessness in her pursuit of excellence has proven an advantageous quality when navigating the uncertain landscape of the healthcare industry. Currently, the industry in Saudi Arabia is undergoing significant transformation, driven by digital innovation and regulatory changes. Whilst these shifts present challenges to organisations, such as maintaining compliance and adapting to new technologies, Dr Almoshary acknowledges that they also create opportunities for advanced patient care and operational efficiency. Championing the healthcare revolution throughout Saudi Arabia, Dr Almoshary has been dedicated to driving research and development across the sector. Having achieved a fellowship from McMaster University and a MBBS degree from King Saud University, she is no stranger to academic research. Dr Almoshary has published countless papers and articles that have further advanced scientific research, covering topics such as cytometry, thrombosis, and blood disorders. What’s more, the doctor has also been committed to advancing scientific education within the country and has been involved in various medical education and training initiatives. Such examples of this include fulfilling the role of Vice Dean of Postgraduate and Scientific Research at Medical College PNU and the role of CEO of Allied Medical Services at KAAUH. Moving forward, Dr Almoshary plans to continue advancing the future of healthcare in Saudi Arabia, ensuring high quality and effective healthcare for all. To achieve this mission, she plans to expand Private Diagnostic’s service offerings, particularly in alignment with the emerging area of digital health. We learn that Dr Almoshary plans to invest in new technologies and strategic partnerships that will enhance accessibility and patient outcomes throughout 2025 and beyond. As for her personal plans, Dr Almoshary intends to continue her professional development over the course of the next year. She will do this by attending leadership workshops to develop her capabilities, as well as engaging with international healthcare networks to stay abreast of industry trends. For her dedication to improving the standards of healthcare throughout the country, as well as the significant contributions she has already made to the development of the industry, Dr Almoshary has been awarded the prestigious title of Hematology Chief Medical Executive of the Year 2024. Contact: Dr. May Abdullah Almoshary Company: Princess Nourah Bint Abdulrahman University Medical College Web Address: https://pnu.edu.sa/ B
RkJQdWJsaXNoZXIy NTY1MjM3